Christopher A. Naranjo

587 total citations
8 papers, 114 citations indexed

About

Christopher A. Naranjo is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Infectious Diseases. According to data from OpenAlex, Christopher A. Naranjo has authored 8 papers receiving a total of 114 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Radiology, Nuclear Medicine and Imaging and 2 papers in Infectious Diseases. Recurrent topics in Christopher A. Naranjo's work include Monoclonal and Polyclonal Antibodies Research (4 papers), Viral Infectious Diseases and Gene Expression in Insects (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Christopher A. Naranjo is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (4 papers), Viral Infectious Diseases and Gene Expression in Insects (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Christopher A. Naranjo collaborates with scholars based in United States and India. Christopher A. Naranjo's co-authors include Michael J. Holtzman, Yong Zhang, Jason Sutin, Cameron Sadegh, Fan Gao, Benjamin C. Warf, Pei‐Yi Lin, Huixin Xu, Ryann M. Fame and Jin Cui and has published in prestigious journals such as Nature Communications, Cancer Research and Biotechnology and Bioengineering.

In The Last Decade

Christopher A. Naranjo

7 papers receiving 112 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher A. Naranjo United States 4 49 48 29 21 13 8 114
Gabriela Vitória Brazil 6 35 0.7× 63 1.3× 6 0.2× 10 0.5× 45 3.5× 9 180
Kazushi Ichikawa Japan 8 64 1.3× 82 1.7× 10 0.3× 36 1.7× 26 2.0× 18 205
Marcos Madruga‐Garrido Spain 7 19 0.4× 100 2.1× 12 0.4× 24 1.1× 8 0.6× 15 201
Christine G. Spaeth United States 9 46 0.9× 62 1.3× 65 2.2× 14 0.7× 22 1.7× 15 250
Dana Knutzen United States 7 30 0.6× 48 1.0× 63 2.2× 10 0.5× 13 1.0× 9 174
Jianmin Zhong China 10 27 0.6× 107 2.2× 34 1.2× 6 0.3× 12 0.9× 27 216
Salleh N. Ehaideb Saudi Arabia 7 31 0.6× 86 1.8× 9 0.3× 10 0.5× 22 1.7× 10 189
Elizabeth A. Normand United States 6 29 0.6× 74 1.5× 67 2.3× 6 0.3× 9 0.7× 7 189
Christelle Rougeot France 6 59 1.2× 81 1.7× 50 1.7× 10 0.5× 5 0.4× 12 183
Raphael Kübler Netherlands 5 27 0.6× 67 1.4× 7 0.2× 13 0.6× 20 1.5× 7 227

Countries citing papers authored by Christopher A. Naranjo

Since Specialization
Citations

This map shows the geographic impact of Christopher A. Naranjo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher A. Naranjo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher A. Naranjo more than expected).

Fields of papers citing papers by Christopher A. Naranjo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher A. Naranjo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher A. Naranjo. The network helps show where Christopher A. Naranjo may publish in the future.

Co-authorship network of co-authors of Christopher A. Naranjo

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher A. Naranjo. A scholar is included among the top collaborators of Christopher A. Naranjo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher A. Naranjo. Christopher A. Naranjo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Dalvie, Neil C., Joseph R. Brady, Christopher A. Naranjo, et al.. (2024). Adaptation of Aglycosylated Monoclonal Antibodies for Improved Production in Komagataella phaffii. Biotechnology and Bioengineering. 122(2). 361–372. 1 indexed citations
2.
Tabrizi, Shervin, Kan Xiong, Timothy Blewett, et al.. (2023). Abstract 3371: A DNA-binding priming agent protects cell-free DNA and improves the sensitivity of liquid biopsies. Cancer Research. 83(7_Supplement). 3371–3371. 1 indexed citations
3.
Rodriguez‐Aponte, Sergio A., Christopher A. Naranjo, Neil C. Dalvie, et al.. (2023). Minimal purification method enables developability assessment of recombinant proteins. Biotechnology and Bioengineering. 121(8). 2423–2434. 1 indexed citations
4.
Dalvie, Neil C., et al.. (2022). Steric accessibility of the N-terminus improves the titer and quality of recombinant proteins secreted from Komagataella phaffii. Microbial Cell Factories. 21(1). 180–180. 4 indexed citations
5.
Lin‐Cereghino, Joan, Christopher A. Naranjo, & Geoff P. Lin‐Cereghino. (2022). Competent Cell Preparation and Transformation of Pichia pastoris. Methods in molecular biology. 2513. 113–120. 2 indexed citations
6.
Kaur, Kawaljit, Ozan S. Kumru, Greta Van Slyke, et al.. (2022). Antigen-adjuvant interactions, stability, and immunogenicity profiles of a SARS-CoV-2 receptor-binding domain (RBD) antigen formulated with aluminum salt and CpG adjuvants. Human Vaccines & Immunotherapeutics. 18(5). 2079346–2079346. 13 indexed citations
7.
Xu, Huixin, Ryann M. Fame, Cameron Sadegh, et al.. (2021). Choroid plexus NKCC1 mediates cerebrospinal fluid clearance during mouse early postnatal development. Nature Communications. 12(1). 447–447. 75 indexed citations
8.
Dalvie, Neil C., Sergio A. Rodriguez‐Aponte, Christopher A. Naranjo, et al.. (2021). Scalable, methanol‐free manufacturing of the SARS‐CoV‐2 receptor‐binding domain in engineered Komagataella phaffii. Biotechnology and Bioengineering. 119(2). 657–662. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026